PAR 0.00% 26.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31

  1. 9,827 Posts.
    lightbulb Created with Sketch. 1249
    The realisation of ongoing P3 costs may be why we're indirectly hearing about "forward sale royalties"

    Not convinced its all over just yet in terms of funding options available rather there is elevated risks we don't get it on terms we had previous hoped.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.000(0.00%)
Mkt cap ! $91.06M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1666 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 66697 1
View Market Depth
Last trade - 09.52am 18/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.